PATENT CLAIM ANALYSIS

Application Number: 16210853
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["424", "523000"]

Abstract:
The disclosure provides a composition for inhibiting thrombosis. The composition includes 5 to 25% by weight of Fish Oil, 15 to 55% by weight of Willow Bark Extract, and 0.2 to 5% by weight of Vitamin E.

Claim (Index 14):
The method of  claim 13 , wherein the subject at risk for venous thrombosis is selected from the group consisting of surgical patients, women who are taking birth control pills or participating in an estrogen regime, males who are taking steroid supplements, patients who have active cancer, patients who have prior incidence of thrombosis, patients who currently have stents and require anti-thrombolytic therapy, diabetic patients known to have thrombotic risk, sedentary individuals, patients that have undergone total hip and/or total knee arthroplasty, patients wearing a cast, patients that are immobilized on bed rest, and combinations thereof.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.51724
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15155920', '13363661', '15232773', '16114815', '13673215']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7211494465319889
- 35 USC 102 Novelty (BERT): 0.5389422286084038
- Combined Prediction Score: 0.7029287247396303
- Mean Citation Score: 192.511106
- Max Citation Score: 352.02045
- Similarity Product: 238.835047410205

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test